Champions Oncology (CSBR) Reports In-Line Q1 EPS

July 26, 2018 4:05 PM EDT

Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.01 million.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings